3176.TWO
Price:
$30.5
Market Cap:
$4.25B
Medigen Biotechnology Corp., a biopharmaceutical company, focuses on the development of therapies for liver diseases and cancers in Taiwan. It offers cell therapies, such as MAGICELL-NK, which are natural killer cells; and MAGICELL-GDT, which are T cells. It also develops OBP-301 that has completed Phase I clinical trials in combination with esophageal cancer in Japan; is in Phase I clinical trials in combination with immune checkpoint inhibitors (ICI) for patients with esophageal cancer in Japan; and in phase II study in combination with ICI for esophageal cancer and gastric cancer patients in the United States. Medigen Biotechnology Corp. was founded in 1999 and is headquartered in Taipei,...[Read more]
Industry
Biotechnology
IPO Date
2007-12-31
Stock Exchange
TWO
Ticker
3176.TWO
According to Medigen Biotechnology Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -40.13. This represents a change of 24.67% compared to the average of -32.19 of the last 4 quarters.
The mean historical PE Ratio of Medigen Biotechnology Corp. over the last ten years is -32.57. The current -40.13 PE Ratio has changed 12.22% with respect to the historical average. Over the past ten years (40 quarters), 3176.TWO's PE Ratio was at its highest in in the June 2024 quarter at 135.77. The PE Ratio was at its lowest in in the September 2024 quarter at -101.61.
Average
-32.57
Median
-19.35
Minimum
-151.61
Maximum
-6.92
Discovering the peaks and valleys of Medigen Biotechnology Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 522.66%
Maximum Annual PE Ratio = -6.92
Minimum Annual Increase = -95.44%
Minimum Annual PE Ratio = -151.61
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -22.05 | 102.79% |
| 2023 | -10.87 | 57.22% |
| 2022 | -6.92 | -95.44% |
| 2021 | -151.61 | 522.66% |
| 2020 | -24.35 | -27.70% |
| 2019 | -33.68 | 143.76% |
| 2018 | -13.82 | 31.35% |
| 2017 | -10.52 | -45.65% |
The current PE Ratio of Medigen Biotechnology Corp. (3176.TWO) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-13.28
5-year avg
-43.16
10-year avg
-32.57
Medigen Biotechnology Corp.’s PE Ratio is less than Senhwa Biosciences, Inc. (-12.83), greater than UnicoCell Biomed Co., Ltd. (-54.07), less than BRIM Biotechnology, Inc. (-15.89), less than Energenesis Biomedical CO.,LTD. (-13.21), greater than Formosa Pharmaceuticals, Inc. (-69.19), less than AnnJi (-13.61), less than TWi Biotechnology, Inc. (-10.78), less than Synbio Tech Inc. (17.04), less than Shine-On BioMedical Co.,Ltd. (-30.12), greater than Sagittarius Life Science Corp (-41.86),
| Company | PE Ratio | Market cap |
|---|---|---|
| -12.83 | $3.58B | |
| -54.07 | $4.81B | |
| -15.89 | $3.69B | |
| -13.21 | $3.77B | |
| -69.19 | $4.23B | |
| -13.61 | $4.33B | |
| -10.78 | $2.05B | |
| 17.04 | $3.25B | |
| -30.12 | $3.54B | |
| -41.86 | $3.22B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medigen Biotechnology Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Medigen Biotechnology Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Medigen Biotechnology Corp.'s PE Ratio?
How is the PE Ratio calculated for Medigen Biotechnology Corp. (3176.TWO)?
What is the highest PE Ratio for Medigen Biotechnology Corp. (3176.TWO)?
What is the 3-year average PE Ratio for Medigen Biotechnology Corp. (3176.TWO)?
What is the 5-year average PE Ratio for Medigen Biotechnology Corp. (3176.TWO)?
How does the current PE Ratio for Medigen Biotechnology Corp. (3176.TWO) compare to its historical average?